Eric Benevich, Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 11,940 shares at $151.74 ($1.8M) on 2025-11-28, disclosed to the SEC on 2025-12-02.
Scheduled sale ($1.8M) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $151.74 | 5,970 | $906K | 50.0% |
| 2 | $151.74 | 5,970 | $906K | 50.0% |
| Total | $151.74 avg | 11,940 | $1.8M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $369K | — | Filing → |
| NBIX | SELL | 2024-04-17 | $5.3M | — | Filing → |